Table 1 Demographic and clinical characteristics of the study population
Variable | Study Population N = 97 | HIV/HCV N = 11 | HCV N = 86 |
|---|---|---|---|
Gender n (%) | |||
Female | 55 (57) | 07 (64) | 48 (56) |
Male | 42 (43) | 04 (36) | 38 (44) |
Mean age in years | 60.2 | 58.9 | 60.4 |
Mean AST (UI/L) | 60.3 (7–259) | 73.6 (26–179) | 58.5 (07–259) |
Mean platelet × 103 (UI/L) | 172 (50–369) | 138 (57–227) | 177 (50–369) |
Mean APRI score | 1.1 (0.1–5.4) | 1.7 (0.4–5.4) | 1 (0.1–3.6) |
Stage F0 n (%) | 36 (37.1%) | 03 (27.3%) | 33 (38.4%) |
Stage F1 n (%) | 20 (20.6%) | 01 (09.1%) | 19 (22.1%) |
Stage F2 n (%) | 11 (11.3%) | 00 (0.0%) | 11 (12.8%) |
Stage F3 n (%) | 13 (13.4%) | 04 (36.3%) | 9 (10.5%) |
Stage F4 n (%) | 17 (17.5%) | 03 (27.3%) | 14 (16.2%) |